283 related articles for article (PubMed ID: 28008779)
1. The Effect of Undaria pinnatifida Fucoidan on the Pharmacokinetics of Letrozole and Tamoxifen in Patients With Breast Cancer.
Tocaciu S; Oliver LJ; Lowenthal RM; Peterson GM; Patel R; Shastri M; McGuinness G; Olesen I; Fitton JH
Integr Cancer Ther; 2018 Mar; 17(1):99-105. PubMed ID: 28008779
[TBL] [Abstract][Full Text] [Related]
2. Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer.
Dowsett M; Pfister C; Johnston SR; Miles DW; Houston SJ; Verbeek JA; Gundacker H; Sioufi A; Smith IE
Clin Cancer Res; 1999 Sep; 5(9):2338-43. PubMed ID: 10499602
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer.
Ingle JN; Suman VJ; Johnson PA; Krook JE; Mailliard JA; Wheeler RH; Loprinzi CL; Perez EA; Jordan VC; Dowsett M
Clin Cancer Res; 1999 Jul; 5(7):1642-9. PubMed ID: 10430063
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.
Muss HB; Tu D; Ingle JN; Martino S; Robert NJ; Pater JL; Whelan TJ; Palmer MJ; Piccart MJ; Shepherd LE; Pritchard KI; He Z; Goss PE
J Clin Oncol; 2008 Apr; 26(12):1956-64. PubMed ID: 18332474
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.
Rasmussen BB; Regan MM; Lykkesfeldt AE; Dell'Orto P; Del Curto B; Henriksen KL; Mastropasqua MG; Price KN; Méry E; Lacroix-Triki M; Braye S; Altermatt HJ; Gelber RD; Castiglione-Gertsch M; Goldhirsch A; Gusterson BA; Thürlimann B; Coates AS; Viale G;
Lancet Oncol; 2008 Jan; 9(1):23-8. PubMed ID: 18083065
[TBL] [Abstract][Full Text] [Related]
6. Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective.
Karnon J; Delea T; Barghout V
Eur J Health Econ; 2008 May; 9(2):171-83. PubMed ID: 17602251
[TBL] [Abstract][Full Text] [Related]
7. Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.
; Mouridsen H; Giobbie-Hurder A; Goldhirsch A; Thürlimann B; Paridaens R; Smith I; Mauriac L; Forbes J; Price KN; Regan MM; Gelber RD; Coates AS
N Engl J Med; 2009 Aug; 361(8):766-76. PubMed ID: 19692688
[TBL] [Abstract][Full Text] [Related]
8. Challenges in the endocrine management of breast cancer.
Mouridsen HT; Rose C; Brodie AH; Smith IE
Breast; 2003 Aug; 12 Suppl 2():S2-19. PubMed ID: 14659138
[TBL] [Abstract][Full Text] [Related]
9. The discovery and mechanism of action of letrozole.
Bhatnagar AS
Breast Cancer Res Treat; 2007; 105 Suppl 1(Suppl 1):7-17. PubMed ID: 17912633
[TBL] [Abstract][Full Text] [Related]
10. Evaluation Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus in Combination With Anticancer Drugs in Human Cancer Orthotopic Mouse Models.
Burney M; Mathew L; Gaikwad A; Nugent EK; Gonzalez AO; Smith JA
Integr Cancer Ther; 2018 Sep; 17(3):755-761. PubMed ID: 29156992
[TBL] [Abstract][Full Text] [Related]
11. The effect of tamoxifen on the pharmacokinetics of letrozole in female rats.
Tao X; Brodie AM; Nnane IP
Biopharm Drug Dispos; 2006 Oct; 27(7):335-44. PubMed ID: 16912967
[TBL] [Abstract][Full Text] [Related]
12. Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.
Boccardo F; Rubagotti A; Conti G; Potenzoni D; Manganelli A; Del Monaco D
Cancer Chemother Pharmacol; 2005 Oct; 56(4):415-20. PubMed ID: 15838655
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Evaluation of Safety of Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus for Use in Cancer Treatment.
Mathew L; Burney M; Gaikwad A; Nyshadham P; Nugent EK; Gonzalez A; Smith JA
Integr Cancer Ther; 2017 Dec; 16(4):572-584. PubMed ID: 29096568
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model.
Long BJ; Jelovac D; Handratta V; Thiantanawat A; MacPherson N; Ragaz J; Goloubeva OG; Brodie AM
J Natl Cancer Inst; 2004 Mar; 96(6):456-65. PubMed ID: 15026471
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of tamoxifen, N-desmethyl tamoxifen and anastrozole in a patient with metastatic breast cancer and chronic hemodialysis.
Langenegger T; Wahl P; Schiesser D; Thürlimann B
Breast Cancer Res Treat; 2006 Nov; 100(2):177-81. PubMed ID: 16688477
[TBL] [Abstract][Full Text] [Related]
17. Fucoidan Extracted from the New Zealand
Lu J; Shi KK; Chen S; Wang J; Hassouna A; White LN; Merien F; Xie M; Kong Q; Li J; Ying T; White WL; Nie S
Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30469516
[TBL] [Abstract][Full Text] [Related]
18. Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.
Crivellari D; Sun Z; Coates AS; Price KN; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens RJ; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Gladieff L; Rabaglio M; Smith IE; Chirgwin JH; Goldhirsch A
J Clin Oncol; 2008 Apr; 26(12):1972-9. PubMed ID: 18332471
[TBL] [Abstract][Full Text] [Related]
19. The effect of anastrozole on the pharmacokinetics of tamoxifen in post-menopausal women with early breast cancer.
Dowsett M; Tobias JS; Howell A; Blackman GM; Welch H; King N; Ponzone R; von Euler M; Baum M
Br J Cancer; 1999 Jan; 79(2):311-5. PubMed ID: 9888474
[TBL] [Abstract][Full Text] [Related]
20. Letrozole in the extended adjuvant setting: MA.17.
Goss PE
Breast Cancer Res Treat; 2007; 105 Suppl 1(Suppl 1):45-53. PubMed ID: 17912635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
